NGNE

#3212
Neurogene, Inc. Common Stock
23.5200 USD
-2.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
23.5200
24.1150
Year Range
15.9300
35.4700
Daily Change
-2.00%
Monthly Change
+9.80%
6 month change
-20.05%
Year Change
-20.05%
Previous Close
24.0000
Open
23.7300
Bid
Ask
Low
23.5200
High
24.1150
Volume
10
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 366.3074 M
  • Employee 131
  • Founded 2018
  • CEO Jonathan Drachman M.D.
  • Website www.neurogene.com
  • Headquarter New York, United States
  • FIGI BBG005Y0QDK1
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.86
Price to sales ratio
—

News